The Buzz | Center on Addiction


Welcome to The Buzz—Center on Addiction's online conversation about addiction and substance use.

Blog Listing

Molly has been marketed to teens and young adults as pure MDMA by dealers across the country, and those who take the drug believe they’re taking pure MDMA.  But according to the Drug Enforcement Agency, only 13% of Molly contains any MDMA whatsoever. 

Medications prescribed by a doctor are an effective, potentially lifesaving, treatment for opioid addiction. These medications reduce drug use and help keep people in treatment longer. In fact, studies show that combining medication with therapy yields the best results for opioid addiction.

When using the same amount of a substance or less, women are more vulnerable to some of the health effects of substance use, including addiction. Additionally, women experience some unique consequences of substance use and addiction, such as breast cancer and complications with pregnancy.

Welcome to Five Minutes With where we take a few moments to better get to know the CASAColumbia staff. Today we’d like to introduce Linda Richter, Associate Director of the Policy Research and Analysis Division.

The Food and Drug Administration (FDA) released a proposed regulation in April and solicited comments on how to regulate tobacco products that are subject to the Family Smoking Prevention and Tobacco Control Act in 2009. Up until now, many tobacco products such as dissolvable tobacco, cigars, cigarillos, hookah, e-cigarettes and pipe tobacco, were not subject to FDA regulation. The FDA is responsible for “regulating the manufacturing, marketing and distribution of tobacco products to protect the public health and to reduce tobacco use by minors.” The fact that many tobacco products have escaped FDA regulation until this time goes against their mission. It is vital that the FDA claim its power to regulate these products.

The Pulse
Center on Addiction’s approach to transforming how our nation addresses addiction relies on:

Newsletter Additional Information

Newsletter Additional Information

Thank you for subscribing

This information will be used to better customize your experience and help inform future tools and features on our website.

Additional Information
What brought you to our website?